Skip to the page

Data / Form D filings / Trait Biosciences Inc.

Trait Biosciences Inc.: Form D filings

Trait Biosciences Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 7 Form D notices with the SEC between 2019 and 2023. The latest, on September 25, 2023, reports $3.7 million sold of a $3.7 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1600 - 1111 West Georgia St., Vancouver, British Columbia, Canada, V6E 4
Phone
(604) 684-4535
Industry
Biotechnology
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1779238

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2023New notice$3,687,316$3,687,3163Sep 12, 2023sec.gov
Nov 23, 2022New notice$230,073$230,0734Nov 16, 2022sec.gov
Nov 23, 2022New notice$101,934$101,9344Jul 22, 2022sec.gov
Nov 23, 2022New notice$209,849$209,8494Apr 6, 2022sec.gov
Oct 22, 2021New notice$618,750$618,7504Oct 18, 2021sec.gov
Mar 31, 2021New notice$12,081,915$12,081,9154Mar 22, 2021sec.gov
Aug 1, 2019New notice$15,148,700$7,574,350$7,574,3504Jul 23, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David Templeton RosenthalDirector
Andrew Templeton HunterExecutive Officer
Hanny David KanafaniExecutive Officer
Ronan David LevyDirector
David William SmalleyExecutive Officer

Every Form D from the week of Sep 25, 2023 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Trait Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.